April 2026 in “Boletín Médico Del Hospital Infantil de México (English Edition)” This study found that 90% of pediatric patients with alopecia areata had comorbidities, including allergic rhinitis and atopic dermatitis, with localized AA being associated with better treatment outcomes and fewer relapses compared to non-localized forms.
6 citations
,
May 2024 in “Clinical and Experimental Dermatology” According to this systematic review, children with alopecia areata experience significant psychosocial impacts, including anxiety, depression, and lower self-esteem, which are exacerbated by increased disease severity and affect quality of life, academic performance, and social interactions.
4 citations
,
March 2025 in “Pediatric Dermatology” This review examines the clinical presentation of alopecia areata in children and compares it to adult-onset cases, noting that data on pediatric cases is scarce and often varies, with reported onset typically between ages 6 and 12.
April 2020 in “IP Indian journal of clinical and experimental dermatology” This study explores autoimmune associations in pediatric patients with alopecia areata at a tertiary care center but reports no new clinical findings.
100 citations
,
July 2018 in “Journal of The American Academy of Dermatology” This study found that alopecia areata is linked with a higher prevalence of systemic and psychiatric diseases, suggesting that physicians should monitor for these potential comorbidities.